Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
Clin Nutr Res ; 10(1): 24-35, 2021 Jan.
Article in English | MEDLINE | ID: mdl-33564650

ABSTRACT

Adequate nutritional intake in elderly individuals improves frailty. Elderly individuals may exhibit improvements in frailty with the use of community care facilities. Therefore, this study evaluated the effects of nutritional intervention in elderly subjects at community care facilities receiving oral nutritional supplements (ONSs) and determined their nutritional status. Sixty-two elderly individuals using community care facilities were divided into the experimental group (EG) (before [n = 31]/after [n = 28]) and control group (CG) (before [n = 31]/after [n = 25]). Subjects in both groups were treated with ONSs (200 mL/200 kcal) for 90 days. However, those in the EG received the product with increased protein; vitamins A, C, D, and E; phosphorus; calcium; and zinc. The data collected included anthropometric data, dietary assessment findings, frailty status (Korean version of the Fatigue, Resistance, Ambulation, Illnesses, and Loss of weight questionnaire), and nutritional status (Mini Nutritional Assessment, MNA). The changes in the two groups were analyzed using the Mann-Whitney U Wilcoxon signed-rank test. Nutritional intervention increased the weight, body mass index, and lean body mass in the EG (p < 0.05). Protein, calcium, and iron levels increased only in the EG (p < 0.05). The MNA score increased and sum of frailty indicators improved in the EG, and the increase in the MNA score in the EG was greater than that in the CG. This study verified the improved anthropometric data and dietary intake in the EG. Thus, the higher number of pre-frailty elderly individuals at facilities of community care indicates the need for adequate nutritional supplementation for frailty management.

2.
Food Funct ; 10(5): 2888-2893, 2019 May 22.
Article in English | MEDLINE | ID: mdl-31070609

ABSTRACT

The aim of this study was to investigate whether supplementation with nattokinase, which is considered one of the most active functional ingredients found in natto, alters hemostatic factors. Subjects presenting with hypercholesterolemia (serum cholesterol: 200-280 mg dL-1) were randomly divided into nattokinase and placebo groups (n = 50, respectively). No significant between-group differences were found at baseline in collagen-epinephrine closure time (C-EPI CT), prothrombin time (PT), or activated partial thromboplastin time (aPTT). After 8 weeks of treatment, the nattokinase group exhibited significant increases in C-EPI CT, PT, and aPTT. The nattokinase group showed significantly greater increases in C-EPI CT (P = 0.001) and aPTT (P = 0.016) than the placebo group. Moreover, at 8 weeks, the nattokinase group showed a significantly higher C-EPI CT than the placebo group (P = 0.001). Additionally, a significant correlation between PT and aPTT was observed (r = 0.491, P < 0.001). In conclusion, nattokinase supplementation was associated with prolonged C-EPI CT and aPTT in nondiabetic and borderline-to-moderate hypercholesterolemic subjects.


Subject(s)
Collagen/metabolism , Dietary Supplements/analysis , Epinephrine/metabolism , Hypercholesterolemia/drug therapy , Soy Foods/analysis , Subtilisins/administration & dosage , Adult , Aged , Female , Humans , Hypercholesterolemia/blood , Hypercholesterolemia/metabolism , Male , Middle Aged , Partial Thromboplastin Time , Prothrombin Time
4.
Biomed Res Int ; 2018: 2571269, 2018.
Article in English | MEDLINE | ID: mdl-29850492

ABSTRACT

PURPOSE: This study was performed to evaluate antifatigue effect of hydrogen water (HW) drinking in chronic forced exercise mice model. MATERIALS AND METHODS: Twelve-week-old C57BL6 female mice were divided into nonstressed normal control (NC) group and stressed group: (purified water/PW-treated group and HW-treated group). Stressed groups were supplied with PW and HW, respectively, ad libitum and forced to swim for the stress induction every day for 4 consecutive weeks. Gross antifatigue effects of HW were assessed by swimming endurance capacity (once weekly for 4 wk), metabolic activities, and immune-redox activities. Metabolic activities such as blood glucose, lactate, glycogen, blood urea nitrogen (BUN), and lactate dehydrogenase (LDH) as well as immune-redox activities such as reactive oxygen species (ROS), nitric oxide (NO), glutathione peroxidase (GPx), catalase, and the related cytokines were evaluated to elucidate underlying mechanism. Blood glucose and lactate were measured at 0 wk (before swimming) and 4 wk (after swimming). RESULTS: HW group showed a higher swimming endurance capacity (p < 0.001) than NC and PW groups. Positive metabolic effects in HW group were revealed by the significant reduction of blood glucose, lactate, and BUN in serum after 4 wk (p < 0.01, resp.), as well as the significant increase of liver glycogen (p < 0.001) and serum LDH (p < 0.05) than PW group. In parallel, redox balance was represented by lower NO in serum (p < 0.01) and increased level of GPx in both serum and liver (p < 0.05) than PW group. In line, the decreased levels of serum TNF-α (p < 0.01), IL-6, IL-17, and liver IL-1ß (p < 0.05) in HW group revealed positive cytokine profile compared to PW and NC group. CONCLUSION: This study shows antifatigue effects of HW drinking in chronic forced swimming mice via metabolic coordination and immune-redox balance. In that context, drinking HW could be applied to the alternative and safety fluid remedy for chronic fatigue control.


Subject(s)
Anti-Inflammatory Agents/therapeutic use , Antioxidants/therapeutic use , Drinking Water , Fatigue/drug therapy , Hydrogen/therapeutic use , Swimming , Animals , Anti-Inflammatory Agents/pharmacology , Antioxidants/pharmacology , Blood Glucose/metabolism , Blood Urea Nitrogen , Body Weight/drug effects , Cytokines/metabolism , Fatigue/blood , Female , Glycogen/metabolism , Hydrogen/pharmacology , Inflammation Mediators/metabolism , L-Lactate Dehydrogenase/metabolism , Lactic Acid/blood , Mice, Inbred C57BL , Nitric Oxide/metabolism , Oxidation-Reduction , Physical Endurance/drug effects , Reactive Oxygen Species/metabolism
5.
Article in English | MEDLINE | ID: mdl-29619067

ABSTRACT

Objective: In order to assess the effectiveness of a hop extract (HE) for postmenopausal symptoms, the effects of Lifenol on ovariectomy-induced osteoporosis, hyperlipidemia, body weight increase, and hot flash were investigated in rats. Methods: Female Sprague-Dawley rats were ovariectomized and subjected to a daily scheduled exercise training (15 min at 15 m/min) or treated with HE (30 or 100 mg/kg, oral) or 17ß-estradiol (100 µg/kg, intraperitoneal) for 12 weeks. Body and visceral fat weights, serum lipid profiles, osteoporotic parameters in serum, and femoral bones were analyzed. Separately, forced running-induced dermal and rectal temperatures and blood flow velocity were measured in ovariectomized rats. Results: Ovariectomy increased blood lipids including triglycerides, total cholesterol, and low-density lipoproteins, leading to visceral fat accumulation and overweight. Estrogen depletion caused osteoporosis, displaying decreased femoral bone weight, bone mineral density and content, and blood phosphorus level. The disturbances in lipid metabolism and bone resorption were recovered by treatment with HE in a dose-dependent manner. In addition, HE treatment shortened the duration of forced running-induced alterations in skin and rectal temperatures by reducing blood flow velocity. Conclusion: The results indicate that HE attenuated overweight, osteoporosis, and hot flash in estrogen-deficient animals by regulating blood lipid profile and fat accumulation, blood estrogen and bone resorption factors, and dermal blood flow.


Subject(s)
Estrogens/blood , Hot Flashes/drug therapy , Humulus , Lipid Metabolism/drug effects , Obesity/drug therapy , Osteoporosis/drug therapy , Phytotherapy , Animals , Bone Density/drug effects , Bone Resorption/prevention & control , Estrogens/deficiency , Female , Femur/drug effects , Femur/metabolism , Intra-Abdominal Fat/metabolism , Obesity/metabolism , Osteoporosis/metabolism , Ovariectomy , Overweight/drug therapy , Overweight/metabolism , Plant Extracts/pharmacology , Plant Extracts/therapeutic use , Postmenopause , Rats, Sprague-Dawley
6.
J Biomed Res ; 31(2): 122-129, 2017 Jan 19.
Article in English | MEDLINE | ID: mdl-28808194

ABSTRACT

Since plant oils are believed to be better than animal fats for cerebrovascular and cardiovascular diseases, the effects of various plant oils and trans-fat on blood lipid profiles and ischemic stroke were investigated. Sprague-Dawley rats were fed a diet containing the oils or trans-fat, and then body weights, blood lipids, and effects on brain infarction and physical dysfunction induced by middle cerebral artery occlusion (MCAO) were analyzed. All the oils and trans-fat, except perilla oil, significantly increased body fats and body weight gain. Sesame oil and trans-fat specifically increased blood cholesterols and triglycerides, respectively, while perilla oil decreased both cholesterols and triglycerides. Perilla oil not only attenuated cerebral infarction, but also restored locomotor activity and rota-rod performances of MCAO rats. It is suggested that perilla oil among oils and fats could be the first choice to reduce the risk of metabolic syndrome and ischemic stroke.

7.
Regul Toxicol Pharmacol ; 78: 53-8, 2016 Jul.
Article in English | MEDLINE | ID: mdl-27112419

ABSTRACT

In Alzheimer disease (AD), amyloid-beta (Aß) peptides induce the degeneration of presynaptic cholinergic system, in which decreased activity of enzyme choline acetyltransferase (ChAT) responsible for acetylcholine synthesis is observed. Cereboost™, an extract of American ginseng extract, contains a high concentration of Rb1 ginsenoside which is a well-known ingredient improving human cognitive function. We investigated the effects of Cereboost™ on learning and memory function of mice challenged with an Aß1-42 peptide and the underlying mechanisms in vitro. Cereboost™ protected against Aß1-42-induced cytotoxicity in F3.ChAT stem cells, and enhanced the ChAT gene expression. Aß1-42 injection into the mouse brain impaired the cognitive function, which was recovered by oral administration of Cereboost™. In addition, Cereboost™ restored brain microtubule-associated protein 2 and synaptophysin as well as acetylcholine concentration. The results demonstrate that Cereboost™ administration recovered the cognitive function of AD model animals by enhancing acetylcholine level via ChAT gene expression and neuroprotection.


Subject(s)
Acetylcholine/metabolism , Alzheimer Disease/prevention & control , Behavior, Animal/drug effects , Brain/drug effects , Choline O-Acetyltransferase/metabolism , Cognition/drug effects , Neuroprotective Agents/pharmacology , Panax/chemistry , Plant Extracts/pharmacology , Acetylcholinesterase/metabolism , Alzheimer Disease/chemically induced , Alzheimer Disease/enzymology , Alzheimer Disease/psychology , Amyloid beta-Peptides , Animals , Avoidance Learning/drug effects , Brain/enzymology , Cell Line , Choline O-Acetyltransferase/genetics , Cholinesterase Inhibitors/isolation & purification , Cholinesterase Inhibitors/pharmacology , Disease Models, Animal , Dose-Response Relationship, Drug , GPI-Linked Proteins/antagonists & inhibitors , GPI-Linked Proteins/metabolism , Male , Maze Learning/drug effects , Mice, Inbred ICR , Microtubule-Associated Proteins/metabolism , Neuroprotective Agents/isolation & purification , Peptide Fragments , Phytotherapy , Plant Extracts/isolation & purification , Plants, Medicinal , Synaptophysin/metabolism , Time Factors , Transfection , Up-Regulation
8.
Nutr Neurosci ; 19(7): 318-26, 2016 Sep.
Article in English | MEDLINE | ID: mdl-24856006

ABSTRACT

OBJECTIVES: Since oils and fats can induce metabolic syndrome, leading to cardiovascular and cerebrovascular diseases, the present study was performed to find out whether the plant oils affect the cerebral hemorrhage in stroke-prone spontaneously hypertensive (SHR-SP) rats. METHODS: From 47 days of age, male SHR-SP rats were given drinking water containing 1% NaCl to induce hypertension, and simultaneously fed semi-purified diets containing 10% perilla oil, canola oil, or shortening. The onset time of convulsion following cerebral hemorrhage was recorded, and the areas of hemorrhage and infarction were analyzed in the stroke brains. RESULTS: In comparison with 58-day survival of SHR-SP rats during feeding NaCl alone, perilla oil extended the survival time to 68.5 days, whereas canola oil shortened it to 45.7 days. Feeding perilla oil greatly reduced the total volume of cerebral hemorrhage from 17.27% in the control group to 4.53%, while shortening increased the lesions to 21.23%. In a microscopic analysis, perilla oil also markedly decreased the hemorrhagic and infarction lesions to 1/10 of those in control rats, in contrast to an exacerbating effect of shortening. In blood analyses, perilla oil reduced blood total cholesterol and low-density lipoproteins which were increased in SHR-SP, but canola oil further increased them and markedly lowered platelet counts. DISCUSSION: Perilla oil delayed and attenuated cerebral hemorrhage by improving hyperlipidemia in hypertensive stroke animals, in contrast to the aggravating potential of canola oil and shortening. It is suggested that perilla oil should be the first choice oil for improving metabolic syndrome in hypertensive persons at risk of hemorrhagic stroke.


Subject(s)
Cerebral Hemorrhage/prevention & control , Dietary Fats, Unsaturated/therapeutic use , Hyperlipidemias/diet therapy , Hypertension/diet therapy , Plant Oils/therapeutic use , Stroke/prevention & control , alpha-Linolenic Acid/therapeutic use , Animals , Brain/pathology , Cerebral Hemorrhage/blood , Cerebral Hemorrhage/etiology , Cerebral Hemorrhage/pathology , Dietary Fats/adverse effects , Dietary Fats, Unsaturated/adverse effects , Fatty Acids, Omega-3/adverse effects , Fatty Acids, Omega-3/therapeutic use , Hyperlipidemias/blood , Hyperlipidemias/etiology , Hyperlipidemias/physiopathology , Hypertension/blood , Hypertension/etiology , Hypertension/physiopathology , Kidney/pathology , Male , Metabolic Syndrome/blood , Metabolic Syndrome/diet therapy , Metabolic Syndrome/etiology , Metabolic Syndrome/physiopathology , Neurons/pathology , Plant Oils/adverse effects , Platelet Count , Random Allocation , Rapeseed Oil , Rats, Inbred SHR , Rats, Inbred WKY , Sodium Chloride, Dietary/adverse effects , Stroke/blood , Stroke/etiology , Stroke/pathology , Survival Analysis , Thrombocytopenia/etiology , alpha-Linolenic Acid/adverse effects
SELECTION OF CITATIONS
SEARCH DETAIL